28
Participants
Start Date
September 23, 2014
Primary Completion Date
November 8, 2017
Study Completion Date
March 14, 2018
Selinexor
Selinexor orally as outlined in the study treatment arm.
Liposomal doxorubicin
Pegylated liposomal doxorubicin at a starting dose of 20 mb/m² as outlined in the treatment arm.
Dexamethasone
Participants will be instructed to take Dexamethasone 40 mg (10 tablets) orally once weekly with meals (ideally with breakfast to minimize insomnia). Participants older than 75 years and patients previously intolerant to 40 mg dosage will be allowed to receive 20 mg (5 tablets) once a week.
H. Lee Moffitt Cancer Center and Research Institute, Tampa
Barbara Ann Karmanos Cancer Institute, Detroit
Collaborators (1)
Karyopharm Therapeutics Inc
INDUSTRY
H. Lee Moffitt Cancer Center and Research Institute
OTHER